AzTrials
AzTrials

Maternal DepressionROSHNINCT02047357

Participatory Intervention to Reduce Maternal Depression and Under Five Child Morbidity

A study testing Learning Through Play Plus in people with Maternal Depression, run by Pakistan Institute of Living and Learning at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To test the efficacy of an innovative affordable intervention program that can be used by non-specialists, including mothers and lady health workers with minimal training in low resource countries such as Pakistan Read more about this study

Who is it for?
Ages 18 to 44 years, women only
Conditions the study is for
Maternal Depression
What is being tested?
Learning Through Play Plus
Could I receive a placebo?
No, everyone receives an active treatment
How many people
774 participants
Where
1 sitePakistan
Study dates
Dec 2013to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 44 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Participants will be included in the study if they are:
  • 18 to 44 years old Mothers with children aged between 0-30 months
  • Resident in the trial site catchments area
  • Ability to complete a baseline assessment

Who cannot join

  • Participants will be excluded from the study if they have:
  • A medical disorder that would prevent participation in clinical trial.
  • Temporary resident unlikely to be available for follow up.
  • Active suicidal ideation or any other severe or physical mental disorder

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Community, Gadap

    Karachi, Sindh, 75780

Other trials in Pakistan

About this study

Official title: Participatory Intervention to Reduce Maternal Depression and Under Five Child Morbidity- A Cluster-Randomized Controlled Trial

To test the efficacy of an innovative affordable intervention program that can be used by non-specialists, including mothers and lady health workers with minimal training in low resource countries such as Pakistan

Read the detailed description

Specific challenges: In Pakistan rates of depression particularly in women are high, as well as other risks to the growth and development of young children and child mortality. Numerous studies provide compelling evidence that maternal depression not only affects mothers but is also associated with long term emotional, cognitive and behavioural problems in children. Depressed mothers are unable to provide primary care necessary for growth of their children during the first 3-years of life, a critical period for child development. Disability due to depressive symptoms (such as fatigue, poor concentration, loss of interest) is likely to affect child-care abilities directly, while impaired social functioning is likely to have indirect consequences through lack of support in childcare. Disturbances in mother-infant relationship in depressed mothers negatively influence the child's development. There is now evidence from some low income countries that effectively delivered participatory group interventions are cost effective intervention for improving maternal and child health. The Community-Based participatory Intervention LTP Plus has been designed to address maternal depression and a parenting program of child psychosocial development through mother-infant play providing stimulation, and support for exploration and autonomy for the infant.The proposed study will test the efficacy of an innovative affordable intervention program that can be used by non-specialists, including mothers and lay health workers with minimal training in low resource countries such as Pakistan.

Project Impact: LTP Plus is proposed as a low cost intervention to improve maternal mental and physical health, reduce infant and children under five years' morbidity and mortality, and promote healthy child development. Learning Through Play (LTP) Plus is a low-literacy, sustainable program intended to provide parents with information on the healthy growth and development of their young children. The LTP research-based activities enhance children's development while simultaneously promoting attachment security through building parents' ability to read and be sensitive to their children's cues and through active involvement in their children's development. Plus the Thinking Healthy Program (THP) which adopts 'here and now' problem-solving approach, THP uses cognitive behavior therapy (CBT) techniques of active listening, changing negative thinking, and collaboration with the family.

Being tested
Learning Through Play Plus
Keywords
Maternal depression, Mother, Child, LTP, Learning Through Play, Healthy thinking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Learning Through Play PlusOther

    Also called Psycho social intervention

    Learning Through Play (LTP) Plus is a low-literacy, sustainable program intended to provide parents with information on the healthy growth and development of their young children. The LTP research-based activities enhance children's development while simultaneously promoting attachment security through building parents' ability to read and be sensitive to their children's cues and through active involvement in their children's development. Plus the Thinking Healthy Program (THP) which adopts 'here and now' problem-solving approach. THP uses cognitive behavior therapy (CBT) techniques of active listening, changing negative thinking, and collaboration with the family.

Study groups in NCT02047357
Study groupRoleWhat they receive
Intervention ArmExperimentalLearning Through Play Plus
Receives: Other: Learning Through Play Plus
ControlNo interventionThis arm will receive no intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. EPDS

    The EPDS is a self-report questionnaire composed of ten items scored on a four-point scale (0-3) designed to assess pregnancy and postpartum depression Cox et al. (1987).

    Measured: Change from Baseline to 3 month

Secondary outcomes (5)
  1. Knowledge of Expectation and Child Development

    A 20-item questionnaire will be used to assess maternal knowledge and expectations for child development in the first three years. A change in mothers' knowledge was reported for Pakistani mothers who participated in LTP (Rahman et al, 2009).

    Measured: Baseline, 3 months and 6 months

  2. Patient Health Questionnaire (PHQ) (Kroenke, Spitzer, Williams et al, 2001)

    The Patient health Questionnaire (PHQ) is a simple 10 item self-report questionnaire can also be administered by a trained research worker. A score of 10 or more is taken as cut -off for depressive disorder

    Measured: Baseline, 3 month and 6 month

  3. Generalized Anxiety Disorder (GAD) 7 (Spitzer, R. L., Kroenke, K., Williams, J. B., & Lowe, B. 2006)

    The GAD-7 is a 7 item scale used to screen for and measure severity of Genralised Anxiety Disorder. Scores of 5, 10 \& 15 are taken as cut-off points for mild, moderate and high

    Measured: Baseline, 3 month and 6 month

  4. Clinical Interview Schedule Revised (CISR)

    The clinical Interview Schedule-Revised is a fully structured diagnostic instrument that was developed from an existing instrument, the Clinical Interview Schedule (CIS), assessing minor psychiatric morbidity in the community, general hospital, occupational and primary care research

    Measured: Baseline, 3 month and 6 month

  5. Quality of life (EQ 5 D)

    It is a measure of health and quality of life. This is a standardised instrument for use as a measure of health outcome; it provides a simple descriptive profile and a single index value for health status.

    Measured: Baseline, 3 month and 6 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2014 (estimated)
  2. Study startDec 2013
  3. Primary completionNov 2015
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
774 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02047357
Sponsor's protocol ID
ROS-PILL-001
Other IDs
LTP-PLUS 001
Acronym
ROSHNI
Status last verified
Oct 2017
First submitted
21 Jan 2014
Last updated
30 Oct 2017
Results posted
No
Data monitoring committee
Yes

Publications

  • Ashraf T, Alvi MH, Ullah A, Kiran T, Gumber A, Sikander S, Chaudhry N, Chaudhry IB, Husain N. Economic evaluation of Learning Through Play Plus in comparison to usual care for depressed mothers alongside a randomised controlled trial. BMC Health Serv Res. 2026 Feb 4;26(1):328. doi: 10.1186/s12913-026-14113-0.

    PubMed 41639802

Questions about this trial

What is this clinical trial studying?

A study testing Learning Through Play Plus in people with Maternal Depression, run by Pakistan Institute of Living and Learning at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

EPDS (time frame: Change from Baseline to 3 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02047357, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in